Beijing Balance Medical Technology Co.,Ltd. Stock

Equities

688198

CNE100005X15

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
113.7 CNY +3.68% Intraday chart for Beijing Balance Medical Technology Co.,Ltd. +5.24% -8.73%
Sales 2024 * 571M 78.8M Sales 2025 * 897M 124M Capitalization 15.52B 2.14B
Net income 2024 * 184M 25.39M Net income 2025 * 310M 42.78M EV / Sales 2024 * 27.2 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 17.3 x
P/E ratio 2024 *
84.2 x
P/E ratio 2025 *
50.1 x
Employees 355
Yield 2024 *
-
Yield 2025 *
-
Free-Float 26.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.68%
1 week+5.24%
Current month+3.60%
1 month-0.06%
3 months+7.23%
6 months-13.50%
Current year-8.73%
More quotes
1 week
105.11
Extreme 105.11
113.87
1 month
104.40
Extreme 104.4
114.43
Current year
99.30
Extreme 99.3
133.00
1 year
97.51
Extreme 97.51
144.00
3 years
91.74
Extreme 91.7357
235.71
5 years
22.14
Extreme 22.1429
235.71
10 years
22.14
Extreme 22.1429
235.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 05-07-10
Director of Finance/CFO 56 17-06-30
Chief Tech/Sci/R&D Officer 53 10-12-31
Members of the board TitleAgeSince
Director/Board Member 60 18-01-31
Director/Board Member 44 05-07-10
Director/Board Member 64 05-04-30
More insiders
Date Price Change Volume
24-04-26 113.7 +3.68% 237,090
24-04-25 109.6 -1.88% 152,575
24-04-24 111.7 +4.05% 293,441
24-04-23 107.4 -3.45% 301,156
24-04-22 111.2 +2.98% 290,054

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Beijing Balance Medical Technology Co Ltd is a China-based company mainly engaged in the research and development (R&D) and production of animal derived interventional medical devices. The Company's products cover three fields: heart valve replacement and repair, implantable interventional therapy for congenital heart disease and surgical soft tissue repair. The heart valve replacement and repair products include artificial biological heart valves and valve forming rings. The implantable interventional therapy products for congenital heart disease include cardiothoracic surgical biological patch, outflow tract single valve patch, atrial defect occlude and others. The surgical soft tissue repair products include neurosurgical biological patch, biological hernia patch and others. The Company operates its businesses mainly in the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
113.7 CNY
Average target price
150 CNY
Spread / Average Target
+31.97%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688198 Stock